ALPS Medical Breakthroughs ETF
SBIO
28 hedge funds and large institutions have $19.6M invested in ALPS Medical Breakthroughs ETF in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
49% more capital invested
Capital invested by funds: $13.2M → $19.6M (+$6.42M)
4.17% more ownership
Funds ownership: 10.26% → 14.43% (+4.2%)
4% more funds holding
Funds holding: 27 → 28 (+1)
0% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 10
3% less call options, than puts
Call options by funds: $463K | Put options by funds: $475K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$3.29M |
| 2 |
Wells Fargo
San Francisco,
California
|
+$1.35M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$705K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$560K |
| 5 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
+$322K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$1.54M |
| 2 |
VF
Virtu Financial
New York
|
-$624K |
| 3 |
LPL Financial
San Diego,
California
|
-$391K |
| 4 |
Jane Street
New York
|
-$347K |
| 5 |
IA
IFP Advisors
Tampa,
Florida
|
-$30K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GT
26
Glenmede Trust
Philadelphia,
Pennsylvania
| $5K | – | – | – |
|
|
TCM
27
Tradewinds Capital Management
Bellingham,
Washington
| $3K | – | – | – |
|
|
RCA
28
Rowland Carmichael Advisors
Scottsdale,
Arizona
| $3K | +$2.5K | +100 | New |
|
|
IA
29
IFP Advisors
Tampa,
Florida
| – | -$30K | -1,330 | Closed |
|
30
Simplex Trading
Chicago,
Illinois
| – | -$13K | -602 | Closed |
|
SBIO Hedge Fund Activity: Q3 2016 in Review
28 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in ALPS Medical Breakthroughs ETF (SBIO) for Q3 2016, worth a combined $19.6M — up 49% from $13.2M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new SBIO positions and 2 closed out — a net gain of 2 holders — while 10 added to existing stakes and 10 trimmed.
The largest buyer was Raymond James & Associates, adding an estimated $3.29M. The largest seller was Commonwealth Equity Services, cutting an estimated $1.54M.
- 28 institutional investors held ALPS Medical Breakthroughs ETF (SBIO) as of Q3 2016, up from 27 in Q2 2016.
- Funds reported $19.6M of ALPS Medical Breakthroughs ETF stock for Q3 2016, up 49% quarter-over-quarter.
- 4 funds opened new ALPS Medical Breakthroughs ETF positions in Q3 2016 and 2 closed out, a net change of +2 holders.
- The largest ALPS Medical Breakthroughs ETF buyer in Q3 2016 was Raymond James & Associates, an estimated $3.29M added.
- The largest ALPS Medical Breakthroughs ETF seller in Q3 2016 was Commonwealth Equity Services, an estimated $1.54M sold.
Based on aggregated 13F filings for Q3 2016.